Lensar (LNSR) Cash from Investing Activities Growth (1y) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -4,224.26% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 95.53% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 3.20% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -18.20% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -208.79% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -187.82% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | -397.90% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -514.25% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | -211.17% |
| 10 | Lensar | 69.32 Mn | 69.61 Mn | 6.38 Mn | 653.30% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 653.30% |
| Dec 31, 2025 | 113.10% |
| Sep 30, 2025 | 541.99% |
| Jun 30, 2025 | -270.52% |
| Mar 31, 2025 | 143.31% |
| Dec 31, 2024 | 150.24% |
| Sep 30, 2024 | -45,150.00% |
| Jun 30, 2024 | -1,017.13% |
| Mar 31, 2024 | -15,225.00% |
| Dec 31, 2023 | -6,856.14% |
| Sep 30, 2023 | 0.00% |
| Jun 30, 2023 | -1,710.00% |
| Mar 31, 2023 | 82.61% |
| Dec 31, 2022 | 63.46% |
| Sep 30, 2022 | 96.88% |
| Jun 30, 2022 | 50.00% |
| Mar 31, 2022 | 59.65% |
| Dec 31, 2021 | -48.57% |
| Sep 30, 2021 | -557.14% |
| Jun 30, 2021 | 85.92% |
| Mar 31, 2021 | -22.58% |
| Dec 31, 2020 | -47.89% |